No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Adipocytokine signaling pathway 3 genes, 7 drugs (DrugBank) and 40 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
2 | Adrenergic signaling in cardiomyocytes 6 genes, 3 drugs (DrugBank) and 27 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
1件: SCN5A |
D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
3 | African trypanosomiasis 3 genes, 6 drugs (DrugBank) and 41 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
4 | AGE-RAGE signaling pathway in diabetic complications 5 genes, 8 drugs (DrugBank) and 50 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
2件: PRKCD, PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
5 | Alcoholism 8 genes, 3 drugs (DrugBank) and 9 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
2件: DRD1, DRD2 |
D01044 |
Flupentixol |
1件: 97 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
6 | Aldosterone synthesis and secretion 3 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: PDE2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
7 | Allograft rejection 5 genes, 7 drugs (DrugBank) and 49 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
8 | Alzheimer disease 11 genes, 8 drugs (DrugBank) and 72 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9 | Amoebiasis 3 genes, 6 drugs (DrugBank) and 41 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
10 | Amphetamine addiction 11 genes, 4 drugs (DrugBank) and 59 diseases shown |
1件: DRD1 |
D01044 |
Flupentixol |
1件: 97 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
11 | AMPK signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
12 | Amyotrophic lateral sclerosis (ALS) 11 genes, 8 drugs (DrugBank) and 72 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
13 | Antifolate resistance 3 genes, 6 drugs (DrugBank) and 53 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
14 | Antigen processing and presentation 1 gene, 5 drugs (DrugBank) and 39 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
15 | Apelin signaling pathway 3 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
16 | Apoptosis 1 gene, 5 drugs (DrugBank) and 39 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 6 genes, 3 drugs (DrugBank) and 8 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
18 | Asthma 2 genes, 7 drugs (DrugBank) and 39 diseases shown |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
19 | Autoimmune thyroid disease 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
20 | Autophagy - animal 2 genes, 1 drug (DrugBank) and 1 disease shown |
2件: PRKCD, PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
21 | Axon guidance 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
22 | B cell receptor signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
23 | Bile secretion 1 gene, 1 drug (DrugBank) and 12 diseases shown |
1件: NR1H4 |
D00734 |
Ursodeoxycholic acid |
12件: 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 299 |
24 | C-type lectin receptor signaling pathway 10 genes, 12 drugs (DrugBank) and 69 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PRKCD |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
25 | Caffeine metabolism 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
26 | Calcium signaling pathway 13 genes, 6 drugs (DrugBank) and 65 diseases shown |
2件: ADORA2A, PDE1B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: DRD1 |
D01044 |
Flupentixol |
1件: 97 |
4件: GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
27 | cAMP signaling pathway 15 genes, 4 drugs (DrugBank) and 12 diseases shown |
8件: ADORA1, ADORA2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
2件: DRD1, DRD2 |
D01044 |
Flupentixol |
1件: 97 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
28 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank) and 7 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
29 | Cell adhesion molecules (CAMs) 5 genes, 4 drugs (DrugBank) and 25 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
30 | Cellular senescence 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
31 | cGMP-PKG signaling pathway 13 genes, 7 drugs (DrugBank) and 66 diseases shown |
5件: ADORA1, PDE2A, PDE3A, PDE3B, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: OPRD1 |
D00729 |
Loperamide |
2件: 13, 97 |
D07113 |
D08144 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
D05113 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
32 | Chagas disease (American trypanosomiasis) 6 genes, 8 drugs (DrugBank) and 42 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
33 | Chemokine signaling pathway 3 genes, 2 drugs (DrugBank) and 9 diseases shown |
2件: JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PRKCD |
D09671 |
Sotrastaurin |
1件: 97 |
34 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
35 | Circadian entrainment 7 genes, 2 drugs (DrugBank) and 13 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
36 | Cocaine addiction 7 genes, 2 drugs (DrugBank) and 9 diseases shown |
2件: DRD1, DRD2 |
D01044 |
Flupentixol |
1件: 97 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
37 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
38 | Complement and coagulation cascades 2 genes, 2 drugs (DrugBank) and 2 diseases shown |
1件: F10 |
D03213 |
Apixaban |
2件: 96, 97 |
1件: SERPINC1 |
D07510 |
Parnaparin |
1件: 97 |
39 | Cortisol synthesis and secretion 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
40 | Cushing syndrome 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
41 | Cytokine-cytokine receptor interaction 13 genes, 17 drugs (DrugBank) and 48 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
42 | Dilated cardiomyopathy (DCM) 7 genes, 8 drugs (DrugBank) and 42 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
43 | Dopaminergic synapse 8 genes, 5 drugs (DrugBank) and 63 diseases shown |
2件: DRD1, DRD2 |
D01044 |
Flupentixol |
1件: 97 |
2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SCN1A |
D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
44 | Drug metabolism - other enzymes 2 genes, 2 drugs (DrugBank) and 9 diseases shown |
1件: HPRT1 |
D00161 |
Mercaptopurine |
5件: 86, 94, 96, 97, 164 |
D04931 |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
45 | ECM-receptor interaction 2 genes, 2 drugs (DrugBank) and 2 diseases shown |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
46 | EGFR tyrosine kinase inhibitor resistance 2 genes, 4 drugs (DrugBank) and 14 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
47 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 2 drugs (DrugBank) and 16 diseases shown |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
48 | Endocytosis 3 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
49 | Epstein-Barr virus infection 9 genes, 12 drugs (DrugBank) and 45 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
50 | Estrogen signaling pathway 2 genes, 3 drugs (DrugBank) and 11 diseases shown |
1件: OPRM1 |
D00729 |
Loperamide |
2件: 13, 97 |
D07113 |
D08144 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
D05113 |
1件: PRKCD |
D09671 |
Sotrastaurin |
1件: 97 |
51 | Fc epsilon RI signaling pathway 2 genes, 7 drugs (DrugBank) and 39 diseases shown |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
52 | Fc gamma R-mediated phagocytosis 2 genes, 1 drug (DrugBank) and 1 disease shown |
2件: PRKCD, PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
53 | Fluid shear stress and atherosclerosis 1 gene, 5 drugs (DrugBank) and 39 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
54 | Focal adhesion 2 genes, 2 drugs (DrugBank) and 2 diseases shown |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
55 | Folate biosynthesis 4 genes, 2 drugs (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
2件: TPH1, TPH2 |
D09973 |
Telotristat |
1件: 97 |
56 | FoxO signaling pathway 2 genes, 2 drugs (DrugBank) and 3 diseases shown |
2件: S1PR1, S1PR4 |
D10930 |
Etrasimod |
1件: 97 |
D10968 |
Ozanimod |
3件: 13, 96, 97 |
57 | GABAergic synapse 17 genes, 2 drugs (DrugBank) and 12 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
1件: SLC6A1 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
58 | Gap junction 2 genes, 1 drug (DrugBank) and 1 disease shown |
2件: DRD1, DRD2 |
D01044 |
Flupentixol |
1件: 97 |
59 | Gastric acid secretion 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
60 | Glucagon signaling pathway 6 genes, 3 drugs (DrugBank) and 57 diseases shown |
1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
61 | Glutamatergic synapse 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
62 | GnRH signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: PRKCD |
D09671 |
Sotrastaurin |
1件: 97 |
63 | Graft-versus-host disease 3 genes, 6 drugs (DrugBank) and 49 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
64 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
65 | Hematopoietic cell lineage 7 genes, 12 drugs (DrugBank) and 63 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
1件: IL2RA |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
1件: ITGA4 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
66 | Hepatitis B 6 genes, 10 drugs (DrugBank) and 45 diseases shown |
1件: IFNAR1 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
67 | Hepatitis C 5 genes, 10 drugs (DrugBank) and 45 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
68 | Herpes simplex virus 1 infection 8 genes, 11 drugs (DrugBank) and 46 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
69 | Hippo signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SMAD7 |
D10956 |
Mongersen |
2件: 96, 97 |
70 | Human cytomegalovirus infection 7 genes, 11 drugs (DrugBank) and 69 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
71 | Human immunodeficiency virus 1 infection 9 genes, 9 drugs (DrugBank) and 68 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
72 | Human papillomavirus infection 7 genes, 12 drugs (DrugBank) and 45 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
73 | Human T-cell leukemia virus 1 infection 14 genes, 16 drugs (DrugBank) and 69 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
74 | Huntington disease 3 genes, 2 drugs (DrugBank) and 12 diseases shown |
2件: GRIN1, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
75 | Hypertrophic cardiomyopathy (HCM) 7 genes, 8 drugs (DrugBank) and 42 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
76 | IL-17 signaling pathway 4 genes, 8 drugs (DrugBank) and 39 diseases shown |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
77 | Inflammatory bowel disease (IBD) 8 genes, 13 drugs (DrugBank) and 41 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
78 | Inflammatory mediator regulation of TRP channels 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: PRKCD, PRKCE, PRKCH, PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
79 | Influenza A 8 genes, 11 drugs (DrugBank) and 46 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
80 | Insulin resistance 4 genes, 6 drugs (DrugBank) and 39 diseases shown |
3件: PRKCD, PRKCE, PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
81 | Insulin signaling pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
82 | Intestinal immune network for IgA production 4 genes, 3 drugs (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
83 | JAK-STAT signaling pathway 13 genes, 14 drugs (DrugBank) and 28 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
84 | Kaposi sarcoma-associated herpesvirus infection 11 genes, 8 drugs (DrugBank) and 61 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
85 | Legionellosis 3 genes, 6 drugs (DrugBank) and 41 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
86 | Leishmaniasis 6 genes, 11 drugs (DrugBank) and 44 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: ITGA4 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
87 | Leukocyte transendothelial migration 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: ITGA4 |
D08083 |
Vedolizumab |
2件: 96, 97 |
88 | Long-term potentiation 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
89 | Longevity regulating pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
90 | Malaria 2 genes, 6 drugs (DrugBank) and 41 diseases shown |
1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
91 | MAPK signaling pathway 10 genes, 8 drugs (DrugBank) and 70 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
92 | Measles 13 genes, 11 drugs (DrugBank) and 27 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
93 | Metabolic pathways 18 genes, 8 drugs (DrugBank) and 48 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: GUCY2C |
D09355 |
Linaclotide |
1件: 97 |
1件: HPRT1 |
D00161 |
Mercaptopurine |
5件: 86, 94, 96, 97, 164 |
D04931 |
9件: PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
2件: TPH1, TPH2 |
D09973 |
Telotristat |
1件: 97 |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
94 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
95 | Mineral absorption 1 gene, 2 drugs (DrugBank) and 16 diseases shown |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
96 | Morphine addiction 27 genes, 6 drugs (DrugBank) and 21 diseases shown |
9件: ADORA1, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: DRD1 |
D01044 |
Flupentixol |
1件: 97 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
1件: OPRM1 |
D00729 |
Loperamide |
2件: 13, 97 |
D07113 |
D08144 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
D05113 |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
97 | mTOR signaling pathway 1 gene, 5 drugs (DrugBank) and 39 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
98 | Natural killer cell mediated cytotoxicity 8 genes, 8 drugs (DrugBank) and 68 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
99 | Necroptosis 7 genes, 10 drugs (DrugBank) and 45 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
100 | Neuroactive ligand-receptor interaction 39 genes, 21 drugs (DrugBank) and 85 diseases shown |
2件: ADORA1, ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
2件: CNR1, CNR2 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
2件: DRD1, DRD2 |
D01044 |
Flupentixol |
1件: 97 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
1件: NR3C1 |
D00689 |
Beclomethasone dipropionate |
2件: 97, 98 |
D07495 |
D00246 |
Budesonide |
10件: 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
D00292 |
Dexamethasone |
20件: 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
D00975 |
D01510 |
D01615 |
D01632 |
D01948 |
D02174 |
D02591 |
D02592 |
D00088 |
Hydrocortisone |
8件: 6, 53, 75, 78, 81, 83, 97, 299 |
D00165 |
Hydrocortisone acetate |
8件: 6, 53, 75, 78, 81, 83, 97, 299 |
D00407 |
Methylprednisolone |
36件: 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
D00751 |
D00979 |
D05000 |
D05001 |
D05002 |
D05000 |
Methylprednisolone hemisuccinate |
2件: 13, 97 |
D00472 |
Prednisolone |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
D00980 |
D00981 |
D00982 |
D01239 |
D01998 |
D02156 |
D03301 |
D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
D00385 |
Triamcinolone |
18件: 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
D00983 |
D00984 |
D00985 |
D06216 |
3件: OPRD1, OPRK1, OPRM1 |
D00729 |
Loperamide |
2件: 13, 97 |
D07113 |
D08144 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
D05113 |
5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 |
D10930 |
Etrasimod |
1件: 97 |
D10968 |
Ozanimod |
3件: 13, 96, 97 |
101 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: PRKCD |
D09671 |
Sotrastaurin |
1件: 97 |
102 | NF-kappa B signaling pathway 3 genes, 7 drugs (DrugBank) and 40 diseases shown |
1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
1件: PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
103 | Nicotine addiction 21 genes, 2 drugs (DrugBank) and 13 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
104 | NOD-like receptor signaling pathway 6 genes, 11 drugs (DrugBank) and 45 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PRKCD |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
105 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 5 drugs (DrugBank) and 39 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
106 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
107 | Olfactory transduction 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: PDE1B, PDE2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
108 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
109 | Oocyte meiosis 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
110 | Osteoclast differentiation 11 genes, 13 drugs (DrugBank) and 71 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
111 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
112 | Oxytocin signaling pathway 9 genes, 3 drugs (DrugBank) and 58 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
113 | Pancreatic cancer 1 gene, 4 drugs (DrugBank) and 14 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
114 | Parathyroid hormone synthesis, secretion and action 5 genes, 4 drugs (DrugBank) and 21 diseases shown |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
115 | Parkinson disease 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
2件: DRD1, DRD2 |
D01044 |
Flupentixol |
1件: 97 |
116 | Pathogenic Escherichia coli infection 1 gene, 5 drugs (DrugBank) and 39 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
117 | Pathways in cancer 14 genes, 16 drugs (DrugBank) and 41 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
118 | PD-L1 expression and PD-1 checkpoint pathway in cancer 12 genes, 10 drugs (DrugBank) and 58 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
119 | Peroxisome 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
120 | Pertussis 4 genes, 9 drugs (DrugBank) and 41 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
121 | Phospholipase D signaling pathway 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
122 | PI3K-Akt signaling pathway 10 genes, 10 drugs (DrugBank) and 23 diseases shown |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
123 | PPAR signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
124 | Primary immunodeficiency 4 genes, 4 drugs (DrugBank) and 12 diseases shown |
2件: CD3D, CD3E |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
1件: IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
125 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
126 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
127 | Proteoglycans in cancer 2 genes, 6 drugs (DrugBank) and 41 diseases shown |
1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
128 | Purine metabolism 12 genes, 5 drugs (DrugBank) and 14 diseases shown |
1件: GUCY2C |
D09355 |
Linaclotide |
1件: 97 |
1件: HPRT1 |
D00161 |
Mercaptopurine |
5件: 86, 94, 96, 97, 164 |
D04931 |
9件: PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
129 | Rap1 signaling pathway 6 genes, 4 drugs (DrugBank) and 17 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
1件: DRD2 |
D01044 |
Flupentixol |
1件: 97 |
3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
130 | Ras signaling pathway 3 genes, 1 drug (DrugBank) and 9 diseases shown |
3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
131 | Regulation of actin cytoskeleton 2 genes, 2 drugs (DrugBank) and 2 diseases shown |
2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
132 | Regulation of lipolysis in adipocytes 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: ADORA1, PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
133 | Renin secretion 10 genes, 4 drugs (DrugBank) and 63 diseases shown |
4件: ADORA1, PDE1B, PDE3A, PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
134 | Renin-angiotensin system 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
135 | Retrograde endocannabinoid signaling 17 genes, 2 drugs (DrugBank) and 18 diseases shown |
1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
136 | Rheumatoid arthritis 6 genes, 12 drugs (DrugBank) and 49 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: IL17A |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
137 | RIG-I-like receptor signaling pathway 3 genes, 6 drugs (DrugBank) and 41 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
138 | Serotonergic synapse 5 genes, 2 drugs (DrugBank) and 10 diseases shown |
3件: GABRB1, GABRB2, GABRB3 |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
2件: TPH1, TPH2 |
D09973 |
Telotristat |
1件: 97 |
139 | Shigellosis 4 genes, 6 drugs (DrugBank) and 39 diseases shown |
3件: PRKCD, PRKCE, PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
140 | Signaling pathways regulating pluripotency of stem cells 3 genes, 4 drugs (DrugBank) and 14 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
141 | Sphingolipid signaling pathway 9 genes, 11 drugs (DrugBank) and 45 diseases shown |
1件: ADORA1 |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: OPRD1 |
D00729 |
Loperamide |
2件: 13, 97 |
D07113 |
D08144 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
D05113 |
1件: PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 |
D10930 |
Etrasimod |
1件: 97 |
D10968 |
Ozanimod |
3件: 13, 96, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
142 | Synaptic vesicle cycle 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: SLC6A1 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
143 | Systemic lupus erythematosus 5 genes, 7 drugs (DrugBank) and 53 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
144 | T cell receptor signaling pathway 11 genes, 11 drugs (DrugBank) and 68 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
145 | Taste transduction 10 genes, 3 drugs (DrugBank) and 16 diseases shown |
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
1件: PDE1B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
3件: SCN2A, SCN3A, SCN9A |
D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
146 | TGF-beta signaling pathway 2 genes, 6 drugs (DrugBank) and 39 diseases shown |
1件: SMAD7 |
D10956 |
Mongersen |
2件: 96, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
147 | Th1 and Th2 cell differentiation 19 genes, 15 drugs (DrugBank) and 60 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL13 |
D08857 |
Anrukinzumab |
1件: 97 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
148 | Th17 cell differentiation 19 genes, 17 drugs (DrugBank) and 60 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
D06314 |
Visilizumab |
2件: 96, 97 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
149 | Thermogenesis 2 genes, 2 drugs (DrugBank) and 17 diseases shown |
1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
150 | Thyroid cancer 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
151 | Tight junction 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
152 | TNF signaling pathway 1 gene, 5 drugs (DrugBank) and 39 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
153 | Toll-like receptor signaling pathway 7 genes, 8 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
154 | Toxoplasmosis 6 genes, 10 drugs (DrugBank) and 44 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
155 | Transcriptional misregulation in cancer 4 genes, 5 drugs (DrugBank) and 27 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: IL2RB |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: PPARG |
D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
D08491 |
156 | Tryptophan metabolism 2 genes, 1 drug (DrugBank) and 1 disease shown |
2件: TPH1, TPH2 |
D09973 |
Telotristat |
1件: 97 |
157 | Tuberculosis 12 genes, 17 drugs (DrugBank) and 72 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11123 |
Mirikizumab |
2件: 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
158 | Type I diabetes mellitus 5 genes, 7 drugs (DrugBank) and 49 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
159 | Type II diabetes mellitus 3 genes, 6 drugs (DrugBank) and 39 diseases shown |
2件: PRKCD, PRKCE |
D09671 |
Sotrastaurin |
1件: 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
160 | Vascular smooth muscle contraction 6 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
D01453 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
4件: PRKCD, PRKCE, PRKCH, PRKCQ |
D09671 |
Sotrastaurin |
1件: 97 |
161 | VEGF signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
162 | Viral carcinogenesis 2 genes, 4 drugs (DrugBank) and 14 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
163 | Viral myocarditis 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
164 | Viral protein interaction with cytokine and cytokine receptor 4 genes, 8 drugs (DrugBank) and 45 diseases shown |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
D03639 |
Daclizumab |
7件: 13, 56, 60, 65, 97, 283, 284 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
165 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
166 | Yersinia infection 2 genes, 6 drugs (DrugBank) and 39 diseases shown |
1件: ITGA4 |
D08083 |
Vedolizumab |
2件: 96, 97 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |